PhaseBio Pharmaceuticals Insider Trades

PHAS

Track insider trading activity from PhaseBio Pharmaceuticals executives and directors. See which insiders are buying and selling PHAS stock.

Trades Last 12 Months

PHAS Price

All Insider Trades for PhaseBio Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Thorp Clay Director
Holding Value $2.57k 36,693 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Hutson Nancy J Director
Holding Value $0 0 shares
Last Trade
May 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Sapir Alex Director
Holding Value $0 0 shares
Last Trade
May 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Holding Value $0 0 shares
Last Trade
May 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$263 3,750 shares
$0.07
$0.07
Loewy Caroline M Director
Holding Value $0 0 shares
Last Trade
May 19, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Holding Value $178 2,538 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178 2,538 shares
$0.07
$0.07
Harrigan Edmund Director
Holding Value $683 9,750 shares
Last Trade
May 19, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263 3,750 shares
$0.07
$0.07
Holding Value $341k 4,857,525 shares
Last Trade
Oct 25, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$241k 1,784,109 shares
$0.14
$0.07
Mow Jonathan P Chief Executive Officer
Holding Value $9.29k 132,502 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.75k 10,918 shares
$0.80
$0.07
Birchall Jonathan Chief Commercial Officer
Holding Value $1.4k 20,000 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16k 20,000 shares
$0.80
$0.07
Burkhardt Glen SVP Of Human Resources
Holding Value $0 0 shares
Last Trade
May 20, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.89k 11,248 shares
$0.79
$0.07
Hanson Kristopher SVP And General Counsel
Holding Value $593 8,463 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.87k 4,831 shares
$0.80
$0.07
Sharp John P Chief Financial Officer
Holding Value $4.61k 65,767 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.83k 6,026 shares
$0.80
$0.07
Arnold Susan Elizabeth Svp, Technical Operations
Holding Value $2.89k 41,236 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.75k 10,917 shares
$0.80
$0.07
Lee John Sang Chief Medical Officer
Holding Value $8.1k 115,500 shares
Last Trade
Feb 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 140,250 shares
$1.13
$0.07
Holding Value $981 14,000 shares
Last Trade
Jun 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.4k 14,000 shares
$3.53
$0.07
York Michael Vp, Corporate Development
Holding Value $495 7,059 shares
Last Trade
May 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.53k 2,897 shares
$3.29
$0.07
Ballance David James Vp, Research And Sci. Affairs
Holding Value $597 8,519 shares
Last Trade
Nov 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.24k 919 shares
$3.53
$0.07
Holding Value $771 11,000 shares
Last Trade
May 09, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146k 11,000 shares
$13.23
$0.07
Tufts Linda Director
Holding Value $2.52k 36,000 shares
Last Trade
Feb 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 36,000 shares
$3.15
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up